Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michalis Stratigos"'
Autor:
Chara Papadaki, Michalis Stratigos, Georgios Markakis, Maria Spiliotaki, Georgios Mastrostamatis, Christoforos Nikolaou, Dimitrios Mavroudis, Sofia Agelaki
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/8e9e70f6dea44981931ed1679bf005b8
Autor:
Chara Papadaki, Michalis Stratigos, Georgios Markakis, Maria Spiliotaki, Georgios Mastrostamatis, Christoforos Nikolaou, Dimitrios Mavroudis, Sofia Agelaki
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-17 (2018)
Abstract Background In primary breast cancer metastases frequently arise from a state of dormancy that may persist for extended periods of time. We investigated the efficacy of plasma micro-RNA (miR)-21, miR-23b, miR-190, miR-200b and miR-200c, relat
Externí odkaz:
https://doaj.org/article/d52fe1ebaa4247a2afeb0f7ee8082013
Autor:
Michalis Stratigos, Giannis Stoupis, Leuteris Tsalikis, Chara Papadaki, Neofytos Maliotis, Dimitrios Mavroudis, Alexia Monastirioti, Georgios Mastrostamatis, Sofia Agelaki, Maria Papadaki
Publikováno v:
Oncotarget
// Chara Papadaki 1 , Giannis Stoupis 2 , Leuteris Tsalikis 1 , Alexia Monastirioti 1 , Maria Papadaki 1 , Neofytos Maliotis 1 , Michalis Stratigos 2 , Georgios Mastrostamatis 1 , Dimitrios Mavroudis 1, 2 and Sofia Agelaki 1, 2 1 Laboratory of Transl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36fecee737ee0acaf99bee9481bd67f6
https://doi.org/10.18632/oncotarget.26629
https://doi.org/10.18632/oncotarget.26629
Autor:
Sophia Agelaki, D. Mavroudis, Michalis Stratigos, Maria Spiliotaki, George Markakis, S Ioannis, Georgios Mastrostamatis, Chara Papadaki
Publikováno v:
Cancer Research. 78:P5-07
Background: Metastasis remains a major threat for patients (pts) with operable breast cancer (BC). Recurrence could arise from a state of tumour dormancy during which there is growth restriction of undetectable micrometastases. The expression of dorm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff5ad2a88c7a6f1710a26bb4d3d16567
https://doi.org/10.1158/1538-7445.sabcs17-p5-07-10
https://doi.org/10.1158/1538-7445.sabcs17-p5-07-10
Autor:
Dimitrios Mavroudis, Vassilis Georgoulias, Alexandra Voutsina, Alexios Matikas, Michalis Stratigos
Publikováno v:
Translational Lung Cancer Research. 5:389-400
Small cell lung cancer (SCLC) is a highly aggressive and lethal malignancy. Despite high initial response rates to systemic chemotherapy, the disease eventually relapses; further treatment only modestly improves outcomes and overall survival (OS) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd2bfb0abbaa43fcb0f2419dd0f98638
https://doi.org/10.21037/tlcr.2016.08.04
https://doi.org/10.21037/tlcr.2016.08.04
Autor:
Michalis Stratigos, Christoforos Nikolaou, Maria Spiliotaki, Sofia Agelaki, Georgios Mastrostamatis, Georgios Markakis, Chara Papadaki, Dimitrios Mavroudis
Publikováno v:
Breast Cancer Research : BCR
Breast Cancer Research, Vol 20, Iss 1, Pp 1-17 (2018)
Breast Cancer Research, Vol 20, Iss 1, Pp 1-17 (2018)
Background In primary breast cancer metastases frequently arise from a state of dormancy that may persist for extended periods of time. We investigated the efficacy of plasma micro-RNA (miR)-21, miR-23b, miR-190, miR-200b and miR-200c, related to dor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99e6eb4442fa7d4615338ca39760d927
http://europepmc.org/articles/PMC6042266
http://europepmc.org/articles/PMC6042266
Autor:
Michalis Stratigos, Dimitrios Mavroudis, Maria Spiliotaki, Chara Papadaki, Georgios Markakis, Georgios Mastrostamatis, Sofia Agelaki
Publikováno v:
Journal of Clinical Oncology. 35:e23030-e23030
e23030 Background: Disease relapse is usually a lethal development following treatment of early BC. Recurrence could arise from a state of tumour dormancy during which there is growth restriction of undetectable micrometastases. The expression of dor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbb0c8c35a0730dee646d7a8faf5544b
https://doi.org/10.1200/jco.2017.35.15_suppl.e23030
https://doi.org/10.1200/jco.2017.35.15_suppl.e23030
Autor:
Sophia Agelaki, E-K Vetsika, Harris Markomanolaki, Michalis Stratigos, G Kallergi, K Makrigiannaki, V. Georgoulias, D. Mavroudis
Publikováno v:
Cancer Research. 76:P2-02
Background: Detection of circulating tumor cells (CTCs) before adjuvant chemotherapy as well as during follow-up is related to poor prognosis in early breast cancer. The presence of HER2-positive CTCs has been also associated with significantly decre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::340af03e5a81ae209800c02f3cbfd342
https://doi.org/10.1158/1538-7445.sabcs15-p2-02-03
https://doi.org/10.1158/1538-7445.sabcs15-p2-02-03